The most profitable idea in aesthetics isn’t a molecule. It’s a feeling — that you’re almost finished, and one more appointment will get you there.
You won’t. That’s the design.
A good part of this industry runs on the same engine as any subscription: the point isn’t to solve your problem, it’s to keep it in gentle, renewable maintenance. Aging is not a condition. Acne-prone skin is not a character flaw. Texture, a little inflammation, the pore you can only find in the ten-times mirror. These are things faces do. “Things faces do” has no price. “A problem we can correct” does, and it corrects beautifully every eight to twelve weeks, forever.
Most of the claims aren’t even lies. They’re half-truths in good lighting. A real study on one ingredient becomes a promise about a finished product it was barely in. “Clinically proven” keeps its lab coat on while meaning something much smaller than you assumed. Urgency gets manufactured around things that are usually normal and often temporary. The science is frequently real; what’s done with it is marketing.
And still, there are excellent practitioners, and treatments that make a measurable difference for the people who actually need them. That’s not in question. You can respect the good work and notice that the business does better when you feel like there’s always one more thing to fix. Both are true. The industry would just prefer you only held the first one.
Wanting to look good isn’t the trap. Desire gets a seat here; it only has to survive the follow-up question. The trap is a lifetime subscription to your own dissatisfaction, sold back to you as self-care.
And none of this is a verdict on you. If you’ve bought the serum, booked the thing, run the twelve steps — no shame; that’s most of us, and the marketing is very good at its job. It just means the questions are worth asking before the next purchase instead of after. What is this actually doing? What’s the evidence — the finished product’s, not the ingredient’s? What does it cost once the first appointment stops being the whole price? And the quiet one underneath all of it: is this a problem, or just a face doing what faces do?
Ask those, and the industry doesn’t lose you. It just doesn’t get to decide when you’re finished. You do.
Continue: Claims & Evidence
Source file
What this article is standing on
- This article argues; it does not reportA cultural criticism piece about how the beauty industry manufactures new problems. Its claims are about rhetoric and framing rather than about what an ingredient or device does, so there is no primary source that would settle them — and attaching regulatory citations to it would be decoration rather than evidence. Recorded deliberately, so that an empty source file here reads as a category rather than an oversight.
- FDA: "Cosmeceutical" Label on CosmeticsThe one documented instance the argument leans on: an entire persuasive vocabulary that has no meaning under the law.
- FTC: Health Products Compliance GuidanceWhat an advertiser must substantiate — and, by omission, how much of the framing around a product is unregulated.
